Thc Biomed Intl Stock Probability of Future Pink Sheet Price Finishing Under 0.038

THCBF Stock  USD 0  0.00  0.00%   
THC Biomed's future price is the expected price of THC Biomed instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of THC Biomed Intl performance during a given time horizon utilizing its historical volatility. Check out THC Biomed Backtesting, THC Biomed Valuation, THC Biomed Correlation, THC Biomed Hype Analysis, THC Biomed Volatility, THC Biomed History as well as THC Biomed Performance.
  
Please specify THC Biomed's target price for which you would like THC Biomed odds to be computed.

THC Biomed Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of THC Biomed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for THC Biomed Intl can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
THC Biomed Intl generated a negative expected return over the last 90 days
THC Biomed Intl has some characteristics of a very speculative penny stock
THC Biomed Intl has accumulated 858.43 K in total debt with debt to equity ratio (D/E) of 0.56, which is about average as compared to similar companies. THC Biomed Intl has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist THC Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, THC Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Biomed Intl sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Biomed's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 3.34 M. Net Loss for the year was (3.07 M) with loss before overhead, payroll, taxes, and interest of (1.03 M).
THC Biomed Intl has accumulated about 1.16 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 29.0% of THC Biomed outstanding shares are owned by corporate insiders

THC Biomed Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of THC Pink Sheet often depends not only on the future outlook of the current and potential THC Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. THC Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding163.9 M

THC Biomed Technical Analysis

THC Biomed's future price can be derived by breaking down and analyzing its technical indicators over time. THC Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of THC Biomed Intl. In general, you should focus on analyzing THC Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

THC Biomed Predictive Forecast Models

THC Biomed's time-series forecasting models is one of many THC Biomed's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary THC Biomed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about THC Biomed Intl

Checking the ongoing alerts about THC Biomed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for THC Biomed Intl help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
THC Biomed Intl generated a negative expected return over the last 90 days
THC Biomed Intl has some characteristics of a very speculative penny stock
THC Biomed Intl has accumulated 858.43 K in total debt with debt to equity ratio (D/E) of 0.56, which is about average as compared to similar companies. THC Biomed Intl has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist THC Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, THC Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Biomed Intl sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Biomed's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 3.34 M. Net Loss for the year was (3.07 M) with loss before overhead, payroll, taxes, and interest of (1.03 M).
THC Biomed Intl has accumulated about 1.16 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 29.0% of THC Biomed outstanding shares are owned by corporate insiders

Other Information on Investing in THC Pink Sheet

THC Biomed financial ratios help investors to determine whether THC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in THC with respect to the benefits of owning THC Biomed security.